Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 11/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 9/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6508034 | 0.77 | FFAR1 (0.68) | PPARGFFAR1MAPTPPARA | |
| SCHEMBL6509096 | 0.73 | PPARG (0.50) | PPARGFFAR1MAPTPPARA | |
| SCHEMBL6529595 | 0.72 | PPARG (0.48) | PPARGFFAR1MAPTPPARAALDH1A1 | |
| SCHEMBL6511223 | 0.70 | PPARG (0.70) | PPARGFFAR1MAPTPPARA | |
| SCHEMBL2565785 | 0.69 | PPARG (0.69) | PPARGFFAR1MAPTPPARAALDH1A1 | |
| SCHEMBL166570 | 0.69 | PPARG (0.74) | PPARGFFAR1MAPTPPARAALDH1A1 | |
| SCHEMBL6505839 | 0.69 | PPARG (0.46) | PPARGFFAR1MAPTPPARAALDH1A1 | |
| SCHEMBL6052086 | 0.69 | PPARG (0.57) | PPARGFFAR1PPARA | |
| SCHEMBL6506192 | 0.69 | MAPT (0.51) | PPARGFFAR1MAPTPPARAALDH1A1 | |
| SCHEMBL6506248 | 0.68 | PTAFR (0.44) | PPARGFFAR1MAPTPPARAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005100331-A2 | ANTIDIABETIC AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2005-10-27 | — | — | WO | claimed |
| WO-2005100331-A2 | ANTIDIABETIC AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2005-10-27 | — | — | WO | disclosed |